Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Non-cash Items (2020 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Non-cash Items for 4 consecutive years, with $24.1 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Non-cash Items rose 7933.33% year-over-year to $24.1 million, compared with a TTM value of $24.1 million through Sep 2023, up 7933.33%, and an annual FY2022 reading of $11.7 million, up 504.87% over the prior year.
  • Non-cash Items was $24.1 million for Q3 2023 at Terns Pharmaceuticals, up from $2.9 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $34.0 million in Q1 2021 and bottomed at $175000.0 in Q2 2022.
  • Average Non-cash Items over 4 years is $10.6 million, with a median of $3.0 million recorded in 2023.
  • The sharpest move saw Non-cash Items tumbled 99.29% in 2022, then surged 7933.33% in 2023.
  • Year by year, Non-cash Items stood at $21.7 million in 2020, then plummeted by 97.74% to $491000.0 in 2021, then skyrocketed by 2287.17% to $11.7 million in 2022, then surged by 105.61% to $24.1 million in 2023.
  • Business Quant data shows Non-cash Items for TERN at $24.1 million in Q3 2023, $2.9 million in Q2 2023, and $3.1 million in Q1 2023.